313859
What predicts HIV late testing in Minnesota?
Objectives:
- To describe trends of HIV late testing in Minnesota
- To compare two definitions of HIV late testing
- To identify factors associated with HIV late testing
Methods: Demographic and clinical data on new HIV/AIDS diagnoses between 2002 and 2011 in Minnesota were obtained from the state’s enhanced HIV/AIDS Reporting System (eHARS) database. The proportion of late testers was calculated using a time-based (developing AIDS within 12 months of diagnosis) or laboratory-based (having a baseline CD4 count ≤ 350 cells/μL) definition. Predictors of HIV late testing were assessed through multivariate logistic regression.
Preliminary results: Between 2002 and 2011, 3,153 individuals were newly diagnosed with HIV/AIDS in Minnesota, of whom 32.6% (time-based criteria) and 51.6% (laboratory-based criteria) were late testers. The rate of HIV late testing using either measure was stable over time. People over 45 years old, Hispanics, African-born immigrants, and those without an indicated risk were more likely to be late testers than other groups.
Conclusion: Despite efforts to diagnose HIV/AIDS in a timely manner, the proportion of late testers remains high. The demographic characteristics of HIV late testers in Minnesota are different from the risk groups traditionally targeted by HIV testing programs.
Learning Areas:
Protection of the public in relation to communicable diseases including prevention or controlPublic health or related education
Public health or related research
Learning Objectives:
Describe the trends of HIV late testing in Minnesota over the last decade.
Identify the predictors of HIV late testing in Minnesota.
Compare the two commonly used measures of HIV late testing (time and laboratory based).
Keyword(s): HIV/AIDS
Qualified on the content I am responsible for because: I am an internationally trained physician with over 2 years of clinical HIV practice in Uganda. This is my master's thesis. The project was undertaken under supervision of personnel at the Minnesota Department of Health and University of Minnesota faculty.
Any relevant financial relationships? No
I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.